UBS Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
|
|||||
|
2025
Q1 | $594K | Sell |
|
|||||
|
2024
Q4 | $818K | Sell |
|
|||||
|
2024
Q3 | $948K | Sell |
|
|||||
|
2024
Q2 | $960K | Sell |
|
|||||
|
2024
Q1 | $1.08M | Sell |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $969K | Sell |
|
|||||
|
2023
Q2 | $1.25M | Sell |
|
|||||
|
2023
Q1 | $1.29M | Sell |
|
|||||
|
2022
Q4 | $1.38M | Sell |
|
|||||
|
2022
Q3 | $1.75M | Sell |
|
|||||
|
2022
Q2 | $2M | Sell |
|
|||||
|
2022
Q1 | $6.46M | Sell |
|
|||||
|
2021
Q4 | $13.1M | Sell |
|
|||||
|
2021
Q3 | $15.8M | Buy |
|
|||||
|
2021
Q2 | $17.3M | Sell |
|
|||||
|
2021
Q1 | $17M | Buy |
|
|||||
|
2020
Q4 | $12.7M | Buy |
|
|||||
|
2020
Q3 | $7.62M | Buy |
|
|||||
|
2020
Q2 | $4.85M | Buy |
|
|||||
|
2020
Q1 | $750K | Buy |
|
|||||
|
2019
Q4 | $53K | Buy |
|